LXRX Q4 2021 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$704M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14,000-93.0% YoY

Gross Profit

-$16M-117742.9% margin

Operating Income

-$25M-180928.6% margin

Net Income

-$26M-182935.7% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

-39.1%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$137M

Total Liabilities

$23M

Stockholders' Equity

$114M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14,000	$199,000	-93.0%
Gross Profit	-$16M	-$793,000	-1978.7%
Operating Income	-$25M	-$7M	-239.6%
Net Income	-$26M	-$5M	-366.1%